Merritronix IPO Review 2026: GMP, ESDM Business, Financials and Bullrun View
Merritronix IPO Review 2026: GMP, ESDM Business, Financials and Bullrun View
A research-grade Bullrun review of Merritronix IPO covering electronics manufacturing, defence and aerospace exposure, financial growth, GMP, valuation, risks and investor view.
Merritronix IPO: Electronics Manufacturing with a Stronger Theme
Merritronix is an Electronics Systems Design and Manufacturing company providing B2B electronic manufacturing services such as component sourcing, PCB assembly, system integration, testing, box-build solutions and finished electronic products. Public summaries describe end-market exposure to defence, aerospace, telecommunications and industrial electronics.
This gives the IPO a stronger narrative than many small SME issues. But ESDM is also execution-heavy. Quality systems, customer approvals, component sourcing and delivery reliability can decide margins.
Bullrun lens: Merritronix combines theme strength with financial momentum, but the high GMP makes valuation discipline even more important.
IPO Terms and GMP
| IPO Detail | Information |
|---|---|
| Status | Upcoming SME IPO |
| Open | 1 June 2026 |
| Close | 3 June 2026 |
| Allotment | 4 June 2026 |
| Listing | 8 June 2026 |
| Price Band | ₹141 to ₹149 |
| Lot Size | 1,000 shares |
| Issue Size | About ₹70.03 crore |
| Fresh Issue | About 47,00,000 shares |
| Exchange | BSE SME |
| Registrar | Bigshare Services Pvt. Ltd. |
| Lead Manager | GYR Capital Advisors Pvt. Ltd. |
| GMP Context | User snapshot shows +₹92 and estimated listing around ₹241 |
Business Model: High-Reliability Electronics
The company operates in a segment where customers care about quality, reliability and delivery discipline. Defence and aerospace exposure can create sticky relationships, but qualification cycles can be long and customer concentration must be checked.
The ESDM opportunity in India is supported by electronics localisation, defence indigenisation and manufacturing outsourcing. Merritronix can benefit if it keeps execution quality high and working capital under control.
Financial Momentum: The Biggest Attraction
Public summaries show revenue rising from about ₹113.56 crore in FY25 to around ₹155.90 crore in FY26, while PAT increased from around ₹8.66 crore to about ₹16.10 crore. EBITDA margin also improved significantly.
This is strong financial momentum, but investors should check order quality, receivable days, customer concentration and inventory funding. High-growth manufacturing can consume cash even when PAT rises.
Valuation and GMP Risk
The strong GMP can create listing excitement, but it also raises expectation risk. Investors should not assume that a strong grey market premium guarantees post-listing performance.
The valuation should be compared with electronics manufacturing peers after adjusting for scale, customer mix, ROCE and cash conversion. Sustainable growth matters more than one strong listing day.
| Analysis Point | Bullrun Interpretation |
|---|---|
| Positive signal | ESDM theme plus strong revenue and PAT growth |
| Main concern | High GMP may lead to overheated expectations |
| Quality check | Customer concentration and order repeatability |
| Cash check | Receivables and inventory funding |
Fresh Issue and Growth Use
The issue is fully fresh in public summaries, which means funds are expected to support the company rather than only exiting shareholders.
- Fund expansion and business growth as disclosed in RHP.
- Support working capital for electronics manufacturing operations.
- Strengthen execution capacity for larger B2B orders.
- Fund general corporate purposes.
Strengths Investors Can Consider
- Differentiated ESDM business model.
- Exposure to defence, aerospace, telecom and industrial electronics.
- Revenue and PAT improved sharply.
- Fresh issue structure supports the company.
- Strong GMP indicates market interest.
Risks and Red Flags
- High GMP can create valuation risk.
- Customer concentration must be checked.
- Component supply and inventory can affect execution.
- SME liquidity may remain volatile.
- Margins can normalize if growth mix changes.
Bullrun Investor View
Merritronix is the strongest thematic IPO in this batch. It deserves serious study, but investors should avoid letting GMP replace fundamental work. Apply only if valuation, cash conversion and order quality are acceptable.
Investor Questions
Is Merritronix IPO good for listing gains?
Listing gains depend on subscription strength, GMP movement, allotment demand and the broader market mood. The current strong GMP should be treated as a short-term sentiment signal, not as a substitute for business analysis.
What should investors check before applying?
Read the RHP, financial statements, objects of the issue, borrowings, working capital, promoter holding, peer valuation and subscription data. For SME IPOs, post-listing liquidity is as important as allotment chance.
Is this IPO suitable for conservative investors?
Conservative investors should avoid applying only because an IPO is live or because GMP is positive. They should apply only where business quality, valuation and liquidity risk are all acceptable.